122
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Cost-related nonadherence for prescription medications: a cross-sectional study in Jordan

ORCID Icon
Pages 497-503 | Received 10 Dec 2020, Accepted 04 Mar 2021, Published online: 14 Mar 2021

References

  • Nazer L, Tuffaha H. Health care and pharmacy practice in Jordan. Can J Hosp Pharm. 2017;70(2):150–155.
  • Jordan population and housing census. Amman (Jordan): Department of Statistics; 2015. Available from: http://census.dos.gov.jo
  • Jordan Pharmacists Association. Pharmacy profession in Jordan. 2016. Available from: http://jpa.org.jo/page/pharmacy-profession-jordan
  • Mukattash T, Alzoubi K, Abu El-Rub E, et al. Prevalence of non-adherence among psychiatric patients in Jordan, a cross sectional study. Int J Pharm Pract. 2016;24(3):217–221.
  • Awwad O, Akour A, Al-Muhaissen S, et al. The influence of patients’ knowledge on adherence to their chronic medications: a cross-sectional study in Jordan. Int J Clin Pharm. 2015;37(3):504–510.
  • Abbass I, Revere L, Mitchell J, et al. Medication nonadherence: the role of cost, community, and individual factors. Health Serv Res. 2017;52(4):1,511–1,33.
  • Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22(6):864–871.
  • Kaufman D, Kelly J, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. J Am Med Assoc. 2002;287:337–344.
  • Rampamba E, Meyer J, Godman B, et al. Evaluation of antihypertensive adherence and its determinants at primary healthcare facilities in rural South Africa. J Comp Eff Res. 2018;7(7):661–672.
  • Soumerai S, Pierre-Jacques M, Fea Z. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006;166:1829–1835.
  • Gibson T, Ozminkowski R, Goetzel R. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11:730–740.
  • Macquart De Terline D, Kane A, Kramoh K, et al. Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income Sub-Saharan countries. PLoS One. 2019;14(7):e0219266.
  • Fadare J, Olamoyegun M, Gbadegesin B. Medication adherence and direct treatment cost among diabetes patients attending a tertiary healthcare facility in Ogbomosho, Nigeria. Malawi Med J. 2015;27(2):65–70.
  • Nashilongo M, Singu B, Kalemeera F, et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther. 2017;31(5–6):565–578.
  • Agbor V, Takah N, Aminde L. Prevalence and factors associated with medication adherence among patients with hypertension in sub-Saharan Africa: protocol for a systematic review and meta-analysis. BMJ Open. 2018;8(3):e020715.
  • Heisler M, Langa K, Eby E, et al. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42:626–634.
  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497.
  • Ong S, Koh J, Toh S, et al. Assessing the influence of health systems on Type 2 Diabetes Mellitus awareness, treatment, adherence, and control: a systematic review. PLoS One. 2018;13(3):e0195086.
  • Safran D, Neuman P, Cea S. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood). 2005;24:W5–152.
  • Tamblyn R, Laprise R, Jea H. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. J Am Med Assoc. 2001;285:421–429.
  • Roblin D, Platt R, Mea G. Effect of increased costsharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care. 2005;43:951–959.
  • Motheral B, Fairman K. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization. Med Care. 2001;39:1293–1304.
  • Madden J, Graves A, Fea Z. Cost-related medication nonadherence and spending on basic needs following implementation of medicare. JAMA. 2008;299:1922–1928.
  • Law MR, Lucy Cheng IA, Dhalla DH, et al. The effect of cost on adherence to prescription medications in Canada. Can Med Assoc J. 2012;184(3):297–302.
  • Cutler R, Fernandez-Llimos F, Frommer M, et al. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982.
  • The Jordan Times. Noncommunicable diseases leading cause of death in Jordan — survey. 2020. [ updated Oct 1 2020]. Available from: https://jordantimes.com/news/local/noncommunicable-diseases-leading-cause-death-jordan-%E2%80%94-survey
  • Rice T, Matsuoka K. The impact of cost-sharing on appropriate utilization and health status: a review of the literature on seniors. Med Care Res Rev. 2004;61:415–452.
  • Hennessy D, Sanmartin C, Ronksley P, et al. Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease. Health Rep. 2016;27(6):3–8.
  • Morgan S, Lee A. Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries. BMJ Open. 2017;7(1):e014287.
  • Heidari P, Cross W, Weller C, et al. Medication adherence and cost-related medication non-adherence in patients with rheumatoid arthritis: a cross-sectional study. Int J Rheum Dis. 2019;22(4):555–566.
  • Centres for Medicare and Medicaid Services. Medicare Current Beneficiary Survey (MCBS) Centres for Medicare and Medicaid Services (CMS). 2017 [ updated May 31 2017]. Available from: https://www.cms.gov/Research‐Statistics‐Data‐and‐Systems/Research/MCBS/index.html
  • World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194.
  • Jarab A, Mukattash T. Exploring variables associated with medication non-adherence in patients with COPD. Int J Clin Pharm. 2019;41(5):1202–1209.
  • Canali G, Tittle V, Seita A. Medication adherence by Palestine refugees living in Jordan who have diabetes: a cross-sectional study. Lancet. 2018;391(2):S213.
  • Jarab A, Mukattash T, Hilan H. Medication non-adherence in patients with osteoporosis: implications for clinical pharmacists and osteoporosis care providers. Curr Clin Pharmacol. 2020;15(3):243–250.
  • World Health Organization. Preventing chronic diseases: a vital investment. 2005. Available from: http://www.who.int/chp/chronic_disease_report/en/.
  • World Health Organization. Global status report on noncommunicable diseases. 2014.
  • Addo B, Sencherey S, Babayara MNK. Medication noncompliance among patients with chronic diseases attending a primary health facility in a Periurban District in Ghana. Int J Chronic Dis. 2018;2018:1–10.
  • Zhao J, Zheng Z, Han X, et al. Cancer history, health insurance coverage, and cost-related medication nonadherence and medication cost-coping strategies in the United States. Value Health. 2019;22(7):762–767.
  • Lee H, Park JH, Floyd JS, et al. Combined effect of income and medication adherence on mortality in newly treated hypertension: Nationwide study of 16 million person‐years. J Am Heart Assoc. 2019;8(16):1–26.
  • Degli Esposti L. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res. 2011;3:47–54.
  • Khera R, Valero-Elizondo J, Das S, et al. Cost-related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2017. Circulation. 2019;140(25):2067–2075.
  • Basheti IA, Saqf El Hait S, Qunaibi EA, et al. Associations between patient factors and medication adherence: a Jordanian experience. Pharm Pract (Granada). 2016;14(1):639.
  • Montez J, Friedman E. Educational attainment and adult health: under what conditions is the association causal? Soc Sci Med. 2015;127:1–7.
  • Chodick G, Shalev V, Gerber Y, et al. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel. Clin Ther. 2008;30(11):2,167–2,79.
  • Fernandez-Lazaro C, Adams D, Fernandez-Lazaro D, et al. Medication adherence and barriers among low-income, uninsured patients with multiple chronic conditions. Res Social Adm Pharm. 2019;15(6):744–753.
  • Mishra S, Gioia D, Childress S, et al. Adherence to medication regimens among low-income patients with multiple comorbid chronic conditions. Health Soc Work. 2011;36(4):249–258.
  • Mekonnen GB, Gelayee DA. Low medication knowledge and adherence to oral chronic medications among patients attending community pharmacies: a cross-sectional study in a low-income country. Biomed Res Int. 2020;2020:1–8.
  • Soumerai S, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006;166(17):1,829–1,35.
  • Awad H, Al-Zu’bi Z, Abdallah AB. A quantitative analysis of the causes of drug shortages in Jordan: a supply Chain perspective. Int Bus Res. 2016;9(6):53–63.
  • Rosenbaum L, Shrank W. Taking our medicine–improving adherence in the accountability era. N Engl J Med. 2013;369(8):694–695.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.